-
AZD2461: Novel PARP Inhibitor Workflows for Breast Cancer...
2026-01-20
AZD2461 is a next-generation poly (ADP-ribose) polymerase inhibitor engineered to address DNA repair pathway vulnerabilities in breast cancer models—especially those with BRCA1 mutations or drug resistance. This guide details applied protocols, advanced use-cases, and troubleshooting strategies to maximize assay reproducibility and scientific impact using APExBIO’s validated AZD2461 compound.
-
Clodronate Liposomes: Precision Macrophage Depletion Reag...
2026-01-20
Clodronate Liposomes enable targeted in vivo macrophage depletion, supporting advanced research in immune cell modulation and cancer immunotherapy. As a macrophage depletion reagent, this product offers robust, reproducible results in transgenic mouse and inflammation models. APExBIO’s K2721 kit is benchmarked for selectivity, tissue specificity, and compatibility with diverse administration routes.